1. Home
  2. FSUN vs VIR Comparison

FSUN vs VIR Comparison

Compare FSUN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$40.16

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.86

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
VIR
Founded
1892
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
FSUN
VIR
Price
$40.16
$10.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$45.00
$19.43
AVG Volume (30 Days)
238.1K
1.6M
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
29.00
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$79.34
$270.22
Revenue Next Year
$14.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.95
$4.75
52 Week High
$42.34
$11.66

Technical Indicators

Market Signals
Indicator
FSUN
VIR
Relative Strength Index (RSI) 59.30 74.11
Support Level $39.38 $8.43
Resistance Level $40.35 $11.66
Average True Range (ATR) 0.75 0.52
MACD -0.14 0.26
Stochastic Oscillator 48.59 94.79

Price Performance

Historical Comparison
FSUN
VIR

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: